Clinical Trials Sponsored by EPID Research

Total 39424 results

Epic Research & Diagnostics, Inc.

Completed

Metabolic Syndrome Feasibility Study (EPIC-009)

Metabolic Syndrome

United States
Epic Research & Diagnostics, Inc.

Completed

ClearView Predicate Comparison Testing

Healthy

United States
Epic Research & Diagnostics, Inc.

Completed

Prognostic Indicators as Provided by the EPIC ClearView (GBMC)

Coronary Artery Disease | Pneumonia | Hypertension | Diabetes | Irritable Bowel Syndrome | Atrial Fibrillation | Asthma | Renal Failure | Emphysema | Cholecystitis | Cirrhosis | Crohn's Disease | Ulcerative Colitis | Acute Renal Failure | Diverticulitis | Pancreatitis | Bronchitis | Valvular Heart Disease | Inflammatory Bowel Disease and other conditions

United States
Epic Research & Diagnostics, Inc.

Unknown

Traumatic Brain Injury Feasibility Study (EPIC-011) (TBI)

Traumatic Brain Injury | Controls

United States
Fundación EPIC

Recruiting

Essential Pro PMCF Study ( rEPIC04E ) (rEPIC04E)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention (ANGELINE)

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery Stenosis

Spain
Fundación EPIC

Active, not recruiting

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO)

Coronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, Coronary

Spain
Fundación EPIC

Completed

NAVISCORE PMCF Study ( rEPIC04F ) (rEPIC04F)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Completed

Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent (LASER EXPAND)

Cardiovascular Diseases | Arterial Disease

Spain
Fundación EPIC

Completed

Xperience Pro PMCF Study (rEPIC04A)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Active, not recruiting

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (Monitor- ACS)

Heart Diseases | Atrial Fibrillation | Arrhythmias, Cardiac | Syncope | Tachycardia

Spain
Fundación EPIC

Active, not recruiting

Registry of Coronary Lithotripsy in Spain. (REPLICA)

Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Arteriosclerosis | Arterial Occlusive Diseases

Spain
Fundación EPIC

Active, not recruiting

PRospective Evaluation Complementing Investigation With Acurate Neo Device (PRECISA)

Aortic Stenosis

Spain
Bayer
Novartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe Ltd

Completed

EPID Multiple Sclerosis Pregnancy Study

Multiple Sclerosis

Finland
Fundación EPIC

Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Coronary Artery Disease

Spain
Fundación EPIC

Recruiting

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Aortic Valve Stenosis | Structural Valve Deterioration

Spain
Fundación EPIC

Recruiting

ANGIOLITE PMCF Study ( rEPIC04F ) (rEPIC04F)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

CAPTURER PMCF Study ( rEPIC04D ) (rEPIC04D)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Fundación EPIC

Recruiting

Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) (RETO 320)

Coronary Artery Disease

Spain
Fundación EPIC

Active, not recruiting

A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. (TANSEI)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Completed

Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis (WATCH-HD)

Heart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Bleeding | Arrhythmias, Cardiac | Renal Disease

Spain
Fundación EPIC

Completed

Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study (SIERRA 75)

Coronary Artery Disease | Ischemic Heart Disease

Spain, Portugal
Epic Research & Diagnostics, Inc.
Scottsdale Healthcare

Unknown

Evaluation of Patients in Chest Pain in the Emergency Room (EPIC-ER)

Acute Cardiac Ischemia

United States
Fundación EPIC

Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (PARIS)

Coronary Artery Disease

Spain
Fundación EPIC

Not yet recruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Coronary Disease
Fundación EPIC

Recruiting

Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions (EMPERATRIZ)

Coronary Disease

Spain
Fundación EPIC

Recruiting

Sequent Extended Study (rEpic06)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Recruiting

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (FAST TRACK)

Aortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases

Spain
Fundación EPIC

Recruiting

Coroflex® ISAR NEO PMCF Study (rEPIC07)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

SUPRAFLEX CRUZ PMCF Study ( rEpic05 ) (Multiflex)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

Navitian PMCF Study ( rEPIC04C ) (rEPIC04C)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain, Portugal
Fundación EPIC

Not yet recruiting

Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions (DR vs DK crush)

Coronary Artery Disease
Fundación EPIC

Recruiting

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients (PATREAL)

Acute Coronary Syndrome | Ischemic Heart Disease

Spain
Fundación EPIC

Completed

NC Xperience PMCF Study( rEPIC04B) (rEPIC04B)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Active, not recruiting

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice (VELAZQUEZ)

Coronary Artery Disease | Ischemic Heart Disease

Spain, Portugal
Epix Pharmaceuticals, Inc.

Terminated

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Pulmonary Hypertension | COPD

United States
Epix Pharmaceuticals, Inc.

Completed

Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

Alzheimer's Disease

United States
Fundación EPIC
Abbott

Recruiting

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial (VULNERABLE)

Coronary Artery Disease | Coronary Disease | Ischemic Heart Disease

Spain
Epix Pharmaceuticals, Inc.

Terminated

A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Alzheimer's Disease

United States
Epix Pharmaceuticals, Inc.

Terminated

Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

Alzheimer's Disease

United States
Epix Pharmaceuticals, Inc.

Completed

A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

Anxiety Disorders

United States
Epix Pharmaceuticals, Inc.

Completed

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Epix Pharmaceuticals, Inc.

Completed

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
EPI-Q

Completed

Validation of a Patient Decision Aid for Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
EPI-Q

Withdrawn

A Prospective, Observational Study of COPD Patients in U.S. Hospitals

Chronic Obstructive Pulmonary Disease
Epic Research & Diagnostics, Inc.
Mission Internal Medical Group

Suspended

Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors (Cardiac-CV)

Cardiovascular Diseases | Coronary Artery Disease

United States
EPI-PHARE

Completed

Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study

Cataract | Surgery | Knee Arthroplasty | COVID-19 Pandemic | Hip Arthroplasty | Pacemaker | Coronary Stent

France
Fundación EPIC
Barcicore-Lab

Completed

Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia (RAIN FLOW)

Myocardial Infarction | Coronary Microvascular Disease

Spain
Laboratorios Liomont
EPIC Research CRO; ILS Clinical Research; Q Square Solutions

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Influenza, Human

Mexico

Clinical Trials Sponsored by EPID Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations